India's elderly population faces rising bone health issues

Joint pain and other joint issues are common complaints among many people in India, even though the country has a young population. However, India is also experiencing a rapid increase in its elderly population, which is expected to reach 140 million by 2031. This demographic change highlights the growing need for effective solutions for healthy ageing. Nutraceuticals are increasingly being recognized for their role in supporting bone and joint health. Conditions such as osteoarthritis (OA) and osteoporosis are significant health challenges among the elderly. OA affects about 15-20% of the Indian population, with women being particularly vulnerable. Osteoporosis also affects around 30-40% of women over 50 and a rising number of men, leading to weakened bones and a higher risk of fractures. Supplements containing vitamin D, glucosamine, chondroitin, and collagen are crucial for maintaining bone density and joint health. These nutraceuticals can help reduce the risk of fractures, manage arthritis symptoms, and improve mobility, especially for older adults. The Indian pharmaceutical industry is increasingly focusing on nutraceuticals as a solution for the healthcare needs of the ageing population. There is a growing awareness of the importance of bone and joint health, making these products more popular for preventive care. It is essential that these nutraceuticals are based on clinical research and ensure high safety and efficacy standards. Preventative care has been a part of Indian tradition, and evidence-based nutraceuticals are seen as important for preserving bone health in the ageing population. The pharmaceutical sector is positioned to enhance mobility and quality of life through safe and effective nutraceutical products backed by scientific research.